Literature DB >> 20553749

A thalamo-hippocampal-ventral tegmental area loop may produce the positive feedback that underlies the psychotic break in schizophrenia.

John E Lisman1, Hyun Jae Pi, Yuchun Zhang, Nonna A Otmakhova.   

Abstract

The N-methyl-D-aspartate receptor (NMDAR) hypofunction model of schizophrenia is based on the ability of NMDAR antagonists to produce many symptoms of the disease. Recent work in rats shows that NMDAR antagonist works synergistically with dopamine to produce delta frequency bursting in the thalamus. This finding, together with other results in the literature, suggests a mechanism for the sudden onset of schizophrenia. Among the thalamic nuclei most activated by NMDAR antagonist is the nucleus reuniens. This nucleus excites the cornu ammonis area 1 (CA1) region of the hippocampus. Experiments indicate that such activation can lead to excitation of dopaminergic cells of the ventral tegmental area by a polysynaptic pathway. The resulting elevation of dopamine in the thalamus will enhance thalamic bursting, thereby creating a loop with the potential for positive feedback. We show through computer simulations that in individuals with susceptibility to schizophrenia (e.g., because of partially compromised NMDAR function), an event that stimulates the dopamine system, such as stress, can cause the system to reach the threshold for thalamic bursting. When this occurs, positive feedback in the loop will cause all components to become highly active and to remain active after the triggering stimulus is removed. This is a physiologically specific hypothesis for the sudden and lasting transition that underlies the psychotic break in schizophrenia. Furthermore, the model provides an explanation for the observed selective activation of the CA1 hippocampal region in schizophrenia. The model also predicts an increase of basal activity in the dopamine system and thalamus; the relevant evidence is reviewed. Copyright 2010 Society of Biological Psychiatry. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20553749      PMCID: PMC3507433          DOI: 10.1016/j.biopsych.2010.04.007

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  98 in total

1.  First in vivo evidence of an NMDA receptor deficit in medication-free schizophrenic patients.

Authors:  L S Pilowsky; R A Bressan; J M Stone; K Erlandsson; R S Mulligan; J H Krystal; P J Ell
Journal:  Mol Psychiatry       Date:  2006-02       Impact factor: 15.992

Review 2.  Bursting of thalamic neurons and states of vigilance.

Authors:  Rodolfo R Llinás; Mircea Steriade
Journal:  J Neurophysiol       Date:  2006-03-22       Impact factor: 2.714

Review 3.  Synchrony in the interconnected circuitry of the thalamus and cerebral cortex.

Authors:  Edward G Jones
Journal:  Ann N Y Acad Sci       Date:  2009-03       Impact factor: 5.691

4.  A PET study of the pathophysiology of negative symptoms in schizophrenia. Positron emission tomography.

Authors:  Steven G Potkin; Gustavo Alva; Kirsten Fleming; Ravi Anand; David Keator; Danilo Carreon; Michael Doo; Yi Jin; Joseph C Wu; James H Fallon
Journal:  Am J Psychiatry       Date:  2002-02       Impact factor: 18.112

5.  Hypermetabolic pattern in frontal cortex and other brain regions in unmedicated schizophrenia patients. Results from a FDG-PET study.

Authors:  M Soyka; W Koch; H J Möller; T Rüther; K Tatsch
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2005-04-18       Impact factor: 5.270

Review 6.  The hippocampal-VTA loop: controlling the entry of information into long-term memory.

Authors:  John E Lisman; Anthony A Grace
Journal:  Neuron       Date:  2005-06-02       Impact factor: 17.173

7.  NMDA-dependent modulation of CA1 local circuit inhibition.

Authors:  H C Grunze; D G Rainnie; M E Hasselmo; E Barkai; E F Hearn; R W McCarley; R W Greene
Journal:  J Neurosci       Date:  1996-03-15       Impact factor: 6.167

Review 8.  Pathways to schizophrenia: the impact of environmental factors.

Authors:  Oliver D Howes; Colm McDonald; Mary Cannon; Louise Arseneault; Jane Boydell; Robin M Murray
Journal:  Int J Neuropsychopharmacol       Date:  2004-03       Impact factor: 5.176

Review 9.  Regulation of drug-taking and -seeking behaviors by neuroadaptations in the mesolimbic dopamine system.

Authors:  David W Self
Journal:  Neuropharmacology       Date:  2004       Impact factor: 5.250

Review 10.  The neonatal ventral hippocampal lesion as a heuristic neurodevelopmental model of schizophrenia.

Authors:  Kuei Y Tseng; R Andrew Chambers; Barbara K Lipska
Journal:  Behav Brain Res       Date:  2008-12-03       Impact factor: 3.332

View more
  55 in total

Review 1.  Excitation, inhibition, local oscillations, or large-scale loops: what causes the symptoms of schizophrenia?

Authors:  John Lisman
Journal:  Curr Opin Neurobiol       Date:  2011-11-11       Impact factor: 6.627

2.  NMDAR antagonist action in thalamus imposes δ oscillations on the hippocampus.

Authors:  Yuchun Zhang; Takashi Yoshida; Donald B Katz; John E Lisman
Journal:  J Neurophysiol       Date:  2012-03-14       Impact factor: 2.714

Review 3.  The reuniens and rhomboid nuclei: neuroanatomy, electrophysiological characteristics and behavioral implications.

Authors:  Jean-Christophe Cassel; Anne Pereira de Vasconcelos; Michaël Loureiro; Thibault Cholvin; John C Dalrymple-Alford; Robert P Vertes
Journal:  Prog Neurobiol       Date:  2013-09-08       Impact factor: 11.685

4.  Increased SNARE Protein-Protein Interactions in Orbitofrontal and Anterior Cingulate Cortices in Schizophrenia.

Authors:  Alfredo Ramos-Miguel; Clare L Beasley; Andrew J Dwork; J John Mann; Gorazd Rosoklija; Alasdair M Barr; William G Honer
Journal:  Biol Psychiatry       Date:  2014-12-19       Impact factor: 13.382

5.  Transient inactivation of the neonatal ventral hippocampus permanently disrupts the mesolimbic regulation of prefrontal cholinergic transmission: implications for schizophrenia.

Authors:  Julie M Brooks; Martin Sarter; John P Bruno
Journal:  Neuropsychopharmacology       Date:  2011-08-03       Impact factor: 7.853

6.  Abnormal stress responsivity in a rodent developmental disruption model of schizophrenia.

Authors:  Eric C Zimmerman; Mark Bellaire; Samuel G Ewing; Anthony A Grace
Journal:  Neuropsychopharmacology       Date:  2013-05-08       Impact factor: 7.853

Review 7.  Major diencephalic inputs to the hippocampus: supramammillary nucleus and nucleus reuniens. Circuitry and function.

Authors:  Robert P Vertes
Journal:  Prog Brain Res       Date:  2015-05-16       Impact factor: 2.453

8.  Convergent Inputs from the Hippocampus and Thalamus to the Nucleus Accumbens Regulate Dopamine Neuron Activity.

Authors:  Stephanie M Perez; Daniel J Lodge
Journal:  J Neurosci       Date:  2018-10-24       Impact factor: 6.167

Review 9.  Brain Biomarkers of Vulnerability and Progression to Psychosis.

Authors:  Tyrone D Cannon
Journal:  Schizophr Bull       Date:  2015-12-09       Impact factor: 9.306

10.  Prefrontal-Thalamic Anatomical Connectivity and Executive Cognitive Function in Schizophrenia.

Authors:  Monica Giraldo-Chica; Baxter P Rogers; Stephen M Damon; Bennett A Landman; Neil D Woodward
Journal:  Biol Psychiatry       Date:  2017-09-28       Impact factor: 13.382

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.